A critical advance in cancer research is emerging with the use of VHH fragments to restore mutated p53. This essential malignant inhibitor protein is frequently disabled in various forms of cancer, resulting https://bookmarktiger.com/story21885514/mini-antibodies-reactivate-tumor-suppressor-p53-new-promising-pathway-for-cancer-management